The status of in vitro toxicity studies in the risk assessment of nanomaterials.

Nanotechnology applications already on the market or in development promise great benefits for humans as well as the environment. Simultaneously, the pressure to advance the development of fast methods for evaluating the potential risks of increased human exposure to nanomaterials is augmented. One way forward would be to enhance the role of in vitro toxicity studies in risk assessment procedures of nanomaterials. However, to maximize the use of in vitro assays for this purpose, their values and limitations need to be revealed. Even in risk assessment frameworks for regular chemicals, in vitro studies play a minor role. A comparative analysis of published in vitro data with nanomaterials demonstrates that there are a number of issues that need resolving before in vitro studies can play a role in the risk assessment of nanomaterials.

[1]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[2]  Mark R Wiesner,et al.  Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. , 2006, Nano letters.

[3]  Vincent Castranova,et al.  Single-walled Carbon Nanotubes: Geno- and Cytotoxic Effects in Lung Fibroblast V79 Cells , 2007, Journal of toxicology and environmental health. Part A.

[4]  Wayne Ouellette,et al.  Cytotoxicity of mesoporous silica nanomaterials. , 2008, Journal of inorganic biochemistry.

[5]  J. Gearhart,et al.  In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[7]  N. Monteiro-Riviere,et al.  Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.

[8]  Alexandra Kroll,et al.  Current in vitro methods in nanoparticle risk assessment: limitations and challenges. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  P. Gustin,et al.  Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties. , 2003, Toxicology and applied pharmacology.

[10]  Aravind Subramanian,et al.  Perturbational profiling of nanomaterial biologic activity , 2008, Proceedings of the National Academy of Sciences.

[11]  K. Xia,et al.  Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. , 2003, Current gene therapy.

[12]  B. Rothen‐Rutishauser,et al.  Role of dendritic cells in the lung: in vitro models, animal models and human studies , 2008, Expert review of respiratory medicine.

[13]  Saber M Hussain,et al.  Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[15]  David B Warheit,et al.  How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  B. Sanderson,et al.  Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. , 2007, Mutation research.

[17]  W. MacNee,et al.  The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.

[18]  François Huaux,et al.  Clastogenic and aneugenic effects of multi-wall carbon nanotubes in epithelial cells. , 2008, Carcinogenesis.

[19]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[20]  V. Castranova,et al.  Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. , 2006, Toxicology letters.

[21]  P. Baveye,et al.  Influence of ionic strength, pH, and cation valence on aggregation kinetics of titanium dioxide nanoparticles. , 2009, Environmental science & technology.

[22]  S. K. Sundaram,et al.  Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[24]  N. Herlin‐Boime,et al.  In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. , 2008, Toxicology.

[25]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[26]  David B Warheit,et al.  Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  R. Pieters,et al.  Lung dendritic cells are stimulated by ultrafine particles and play a key role in particle adjuvant activity. , 2008, The Journal of allergy and clinical immunology.

[28]  V. Castranova,et al.  Comparison of the Biological Activity Between Ultrafine and Fine Titanium Dioxide Particles in RAW 264.7 Cells Associated with Oxidative Stress , 2008, Journal of toxicology and environmental health. Part A.

[29]  Manuel Arruebo,et al.  Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. , 2008, Small.

[30]  J. Schlager,et al.  DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. , 2008, Toxicology and applied pharmacology.

[31]  Laetitia Gonzalez,et al.  Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  J. West,et al.  Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  David M. Brown,et al.  Measurement of reactive species production by nanoparticles prepared in biologically relevant media. , 2007, Toxicology letters.

[34]  J. Schnekenburger,et al.  Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media , 2008 .

[35]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[36]  G Chambers,et al.  Single walled carbon nanotubes induce indirect cytotoxicity by medium depletion in A549 lung cells. , 2008, Toxicology letters.

[37]  Chao Liu,et al.  Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition , 2009, Journal of applied toxicology : JAT.

[38]  Akiko Yamamoto,et al.  Cytotoxicity evaluation of ceramic particles of different sizes and shapes. , 2004, Journal of biomedical materials research. Part A.

[39]  Agnes B Kane,et al.  Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing. , 2008, Small.

[40]  R. L. Jones,et al.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. , 2008, The journal of physical chemistry. B.

[41]  Deng-Fwu Hwang,et al.  In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. , 2007, Environmental science & technology.

[42]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[43]  Håkan Wallin,et al.  Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.

[44]  H. Igisu,et al.  Hemolysis Caused by Titanium Dioxide Particles , 2008 .

[45]  Christian Mühlfeld,et al.  In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter , 2008, Expert opinion on drug metabolism & toxicology.

[46]  Jian Qin,et al.  The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. , 2006, Nano letters.

[47]  Conrad Coester,et al.  Particle and Fibre Toxicology BioMed Central Methodology , 2008 .

[48]  H. Karlsson,et al.  Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. , 2008, Chemical research in toxicology.

[49]  Wei Yang,et al.  Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.

[50]  K. Landfester,et al.  Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.

[51]  Manuela Semmler-Behnke,et al.  The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. , 2008, American journal of respiratory cell and molecular biology.

[52]  M. Lag,et al.  IL-1beta differently involved in IL-8 and FGF-2 release in crystalline silica-treated lung cell co-cultures , 2008, Particle and Fibre Toxicology.

[53]  T S Nawrot,et al.  Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10 , 2008, European Respiratory Journal.

[54]  Jinhee Choi,et al.  Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. , 2008, Toxicology.

[55]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  David M. Brown,et al.  Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.

[57]  Vincent Castranova,et al.  Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity , 2007 .

[58]  W. Chan,et al.  Nanotoxicity: the growing need for in vivo study. , 2007, Current opinion in biotechnology.

[59]  C. L. Tran,et al.  Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008 .

[60]  J. Veranth,et al.  Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts , 2007, Particle and Fibre Toxicology.

[61]  Robert N Grass,et al.  Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. , 2007, Environmental science & technology.

[62]  E Sabbioni,et al.  Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. , 2008, Mutagenesis.

[63]  Patries M Herst,et al.  Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. , 2005, Biotechnology annual review.

[64]  P. Dutta,et al.  Inflammatory properties of iron-containing carbon nanoparticles. , 2007, Chemical research in toxicology.

[65]  Julia Xiaojun Zhao,et al.  Toxicity of luminescent silica nanoparticles to living cells. , 2007, Chemical research in toxicology.